DWA
ALPN

Dorsey Wright & Associates’s Alpine Immune Sciences Inc ALPN Stock Holding History

Dorsey Wright & Associates’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,273
Closed -$26K – 303
2023
Q3 		$26K Sell
2,273
-78
-3% -$960 0.01% 199
2023
Q2 		$24.2K Buy
+2,351
New +$21.2K 0.01% 222
2021
Q2 		– Sell
-3,380
Closed -$35.8K – 368
2021
Q1 		$35.8K Buy
+3,380
New +$42.1K 0.42% 129

Other funds holding ALPN

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dorsey Wright & Associates's ALPN Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2023, closing a stake of 2,273 shares — an estimated $26K sold.

Dorsey Wright & Associates first reported a position in ALPN in Q1 2021 and held it in 3 quarters. The position peaked at $35.8K in Q1 2021. 133 funds tracked by Wall St. Rank hold ALPN as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Alpine Immune Sciences Inc position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,273 Alpine Immune Sciences Inc shares in Q4 2023, an estimated $26K.
  • Dorsey Wright & Associates first reported a position in Alpine Immune Sciences Inc in Q1 2021 and held it in 3 quarters.
  • Dorsey Wright & Associates's Alpine Immune Sciences Inc position peaked at $35.8K in Q1 2021.
  • 133 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.